Dr. Shailendra K. Saxena, MD

Dr. Saxena practices at Omaha Children's Surgery Center in Omaha, Nebraska.

Dr. Saxena's NPI, 1285643403, was assigned on August 5, 2006. Dr. Saxena holds Nebraska license 20848.

Dr. Saxena's primary practice is Omaha Children's Surgery Center, at 2727 S 144th St, Omaha, NE 68144 in Douglas County. The practice phone is (402) 513-0318.

Dr. Saxena's primary practice is Omaha Children's Surgery Center in Omaha, Nebraska. Dr. Saxena is also affiliated with Nebraska Medical Center. The medical group on file is Health Care For The Family. Dmand AI also links Dr. Saxena to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saxena practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Saxena's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Saxena is licensed in Nebraska.

CMS data shows 702 Medicare services from Dr. Saxena across 10 procedure codes in 2024, for 117 Medicare patients. Medicare paid $34,255 for them. Every service was in an office.

CMS counts 117 Medicare patients who saw Dr. Saxena in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 74% have high cholesterol. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Saxena's median patient age at 62, with 42% women.

In 2024, Dr. Saxena wrote 4,105 Medicare Part D claims for 245 patients. 83% of them were for generic drugs. CMS names the drug for 3,632 of them, across 94 drugs with 11 or more claims each, at $439,681 in total drug cost. In 2023, CMS named 3,378 claims across 90 drugs.

Dr. Saxena accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 90 papers to Dr. Saxena, published from 2010 to 2025. 2020 was the busiest year, with 18. The most frequent topics are COVID-19, SARS-CoV-2 and Antiviral Agents. Dr. Saxena has published most often in Virusdisease. Dr. Saxena's most frequent co-authors are Ankur Gupta, MD, PhD, Amita Jain, MD and Sanjay K. Nigam, MD.

CMS Open Payments shows 390 general payments to Dr. Saxena from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $1,136.